Recent 13F filings as of December 2025 show that 132 institutional investors hold a position in MBX Biosciences, Inc. (NASDAQ:MBX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 6,652,013 | 0 | 0.00% | $209,804,490.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,935,203 | -67,684 | -1.69% | $124,116,303.00 |
| NEA Management Company, LLC | 31 Dec, 2025 | 3,614,486 | 0 | 0.00% | $114,000,888.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 3,349,961 | -1,473,375 | -30.55% | $105,657,771.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 3,249,790 | 99,790 | 3.17% | $102,498,377.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,919,756 | 962,295 | 49.16% | $92,089,105.00 |
| NVP Associates, LLC | 31 Dec, 2025 | 2,136,335 | 0 | 0.00% | $67,380,006.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 2,123,604 | 0 | 0.00% | $66,978,470.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,817,811 | 140,449 | 8.37% | $57,333,759.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,408,159 | -131,480 | -8.54% | $44,413,335.00 |
| Cormorant Asset Management, LP | 31 Dec, 2025 | 1,120,000 | -105,000 | -8.57% | $35,324,800.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 1,018,600 | 1,018,600 | 0.00% | $32,126,644.00 |
| Woodline Partners LP | 31 Dec, 2025 | 1,000,063 | -201,087 | -16.74% | $31,541,987.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 934,799 | -1,065,201 | -53.26% | $29,483,560.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 890,000 | 890,000 | 0.00% | $28,070,600.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 809,857 | -186,226 | -18.70% | $25,542,890.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 680,609 | 52,942 | 8.43% | $21,466,408.00 |
| STATE STREET CORP | 31 Dec, 2025 | 672,740 | 353,466 | 110.71% | $21,218,220.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 671,838 | 671,838 | 0.00% | $21,189,771.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 650,000 | 0 | 0.00% | $20,501,000.00 |